Clinical Trials Logo

Filter by:
NCT ID: NCT03812094 Completed - Nocturnal Enuresis Clinical Trials

Basic Bladder Advice and Alarm Therapy in Nocturnal Enuresis

BAAT
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Enuresis is the scientific term for bedwetting. Modern research has established three pathogenic mechanisms as crucial: 1. Excessive urine production at night (nocturnal polyuria). 2. Detrusor over activity. The bladder may contract regardless of whether it is full or not. 3. Difficulties to arouse from sleep and will not wake up when the bladder is full or contracts. Children with daytime incontinence usually suffer from detrusor over activity and many of them are constipated. The reason for this connection is probably partly anatomical; constipated children have to use the rectum as a storage space, and the chronically distended rectum will compress the bladder from behind. The link between constipation and enuresis (as opposed to daytime incontinence) is less clear although it is logically plausible. Our experience is that some enuretic children become dry at night just by treatment of constipation, but this is yet not supported by sufficient evidence The standard primary treatment of enuresis - as reflected by global consensus guidelines - rests upon three pillars. The recommended first step is 1) bladder advice. The next step, if the child is still wet at night, is either 2) the antidiuretic drug desmopressin or 3) the sleep-modifying enuresis alarm. The underlying idea behind basic bladder advice is that the child is taught to more actively take command over the bladder by voiding according to a regular daytime schedule, using correct voiding posture and spread fluid intake evenly across the day. The rationale behind the recommendation of this strategy is that is the established cornerstone of the treatment of daytime incontinence and that detrusor over activity is a pathogenic factor common to both conditions. By influencing bladder, function during the day it is assumed that nocturnal bladder function will also normalize. The problem is a glaring lack of evidence. Our primary aims with this study is to better understand which roles basic bladder advice, constipation therapy and/or the enuresis alarm play in the first-line therapy of enuresis.

NCT ID: NCT03808181 Completed - Clinical trials for Chronic Ulcer at Lower Leg

An Open, Single-arm, Multi Centre Pilot Investigation to Evaluate the Debriding Effect of ChloraSolv® on Chronic Wounds

Start date: January 31, 2019
Phase: N/A
Study type: Interventional

The primary objective of this clinical investigation is to evaluate the debriding effect of ChloraSolv® on chronic (more than 1 moth) lower leg ulcer.

NCT ID: NCT03807193 Completed - Clinical trials for Generalized Anxiety Disorder

Self-selected or Predetermined Internet-based Treatment for Generalized Anxiety Disorder With Different Types of Support

Start date: February 12, 2019
Phase: N/A
Study type: Interventional

This study evaluates two types of internet-based treatments for generalized anxiety disorder and two types of support. The treatments are a predetermined program for generalized anxiety disorder and a self-selected treatment. The different types of support are either a weekly contact trough a secure message system or support on demand.

NCT ID: NCT03807154 Completed - Loneliness Clinical Trials

Guided Online Self-help for Loneliness

Start date: January 17, 2019
Phase: N/A
Study type: Interventional

The study seeks to investigate the efficacy of two internet-based self-help programmes administered with support from a therapist. The two active conditions consist of an internet cognitive behavioral therapy (ICBT) programme and a intervention of internet-based interpersonal psychotherapy (IIPT), both of which have been developed for the present study. The active conditions will be compared to a wait-list control group. Participants will be recruited in Sweden with a nationwide recruitment.

NCT ID: NCT03787810 Completed - Clinical trials for Acute Coronary Syndrome

Left Ventricular Dysfunction in Critically Ill Patients

LEVEDYCIP
Start date: May 28, 2018
Phase:
Study type: Observational

Left ventricular dysfunction is common in the critically ill. The aim of this study is to assess the incidence and prognosis of left ventricular dysfunction in critically ill patients.

NCT ID: NCT03784612 Completed - Clinical trials for Type 2 Diabetes Mellitus

The Healthy Eating With APP technologY Study

HAPPY
Start date: January 15, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of using new app-based technology to improve dietary habits, compared to usual care in patients with type 2 diabetes. The hypothesis is that the intervention, i.e. using the new technology an an app-based course for healthy eating habits, will have a greater positive effect on dietary habits and biological markers, including HbA1c and serum lipids, than usual care.

NCT ID: NCT03783078 Completed - Clinical trials for Merkel Cell Carcinoma

Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

Start date: February 25, 2019
Phase: Phase 3
Study type: Interventional

This is a single-arm, open-label, multicenter, efficacy, and safety study of pembrolizumab in adult and pediatric participants with previously untreated advanced Merkel Cell Carcinoma (MCC). The primary objective of the trial is to assess the objective response rate, as assessed by blinded independent central review per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) modified to follow a maximum of 10 target lesions and a maximum of 5 target lesions per organ, following administration of pembrolizumab.

NCT ID: NCT03782740 Completed - Endometriosis Clinical Trials

Effect of Melatonin on Reduction of Pelvic Pain

Start date: March 15, 2019
Phase: Phase 2
Study type: Interventional

In two double blinded randomized controlled trials (RCT) we will study the effect of pain reduction of melatonin vs placebo in women with severe dysmenorrhea and women with endometriosis.The aim is to find an effective method for pelvic pain caused by dysmenorrhea and endometriosis.The primary outcome is reduction of pain in patients with dysmenorrhea and endometriosis respectively when treated with melatonin vs placebo. Secondary outcomes include the effect on daily life, quality of life and cognition. Sleep will also be assessed to evaluate its potential relation to quality of life and cognition.

NCT ID: NCT03782649 Completed - Diabetes Mellitus Clinical Trials

Performance Evaluation of a Novel Non-invasive Glucometer, Calibrated Against Validated Interstitial Glucose References

Start date: November 29, 2018
Phase: N/A
Study type: Interventional

This clinical study has been launched to collect spectral Raman data on the Investigational Medical Device (IMD) compared with reference methods in terms of interstitial fluid samples and capillary and venous references.

NCT ID: NCT03782467 Completed - Neoplasms Clinical Trials

Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015

Start date: January 30, 2019
Phase: Phase 1
Study type: Interventional

The aim of the study is to investigate the safety and tolerability of ATOR-1015 when administered as repeated intravenous infusions to patients with advanced and/or refractory solid malignancies.